With Bidens Agenda in the Balance Lobbying Kicks Into High Gear

WASHINGTON – Central House Democrats have been working to block or remove President Biden’s $3.5 trillion social security network and the provisions of a major climate program, which has resulted in many states and districts becoming online ads. I will not spare a compliment.

Arizona Senator Kirsten Kino has emerged as a leading supporter of the bill, which he described as an “independent voice” and a “non-partisan leader.” Others said Oregon spokesman Kurt Schrader was pushing Biden Schrader’s agenda but firmly opposed a key part of the presidential package. A third praised New York spokeswoman Kathleen Rice for “fighting for our health and our economy,” despite being part of Biden’s plan.

There’s one thing the ads don’t specifically say. It is paid for by groups funded by pharmaceutical industry and business interests that are fighting to kill or overhaul key parts of the president’s plan.

Democrats are trying to turn Biden’s proposal into deep internal divisions in Congress, and a powerful and influential campaign is responding everywhere. Corporate groups are trying to counter most of them, including raising taxes on the rich and corporate. Add dental, hearing, and visual services to Medicare. Proposed taxes and duties to reduce CO2 emissions.

These efforts are less visible than previous lobbying activities. The corridor outside the offices of the Senate Finance Committee, long known as Guccigarch, is an elegant Italian corridor as pandemic restrictions limit large lobbying rallies in the Capitol. Not full of shoes. But the campaign is going harder than ever through one-on-one meetings, zoom calls, fundraising, and broadcasts.

More than 4,000 lobbyists deal with budgets and spending, according to OpenSecrets, a non-profit watchdog that monitors money in politics. According to the group, the top 10 industries spent nearly $700 million on lobbying this year.

The US Chamber of Commerce, which is working to crush the tax hike bill, has spent about $30 million on lobbyists this year. The pharmaceutical industry trying to beat proposals for measures to lower drug prices has cost more than $15 million.

“All groups come and want to meet,” said Senator Elizabeth Warren, a Massachusetts Democrat. “If you don’t get acceptance at the first meeting, you need a second meeting, then a third meeting, a fourth meeting. You are very careful.”

The Influence Campaign paved the way for both. Several political action committees and other influential groups are free to expand the bill further and encourage its adoption.

The Coalition for a Better Recovery formed to support the proposal spent about $7 million this month on advertising, including promoting that “CEOs and major pharmacies” “lie to” voters about Biden’s plans. Ricefield. The Nature Conservation Federation, which spent about $6.7 million this month, is calling on Congress to halve carbon emissions by 2030, which is part of the package, and proposed donations to a Democratic Party campaign he does not support. I threatened to keep it.

Perhaps no package has lobbied as much as a proposal to lower prescription drug prices through Medicare negotiated fees. The pharmacy lobby spent more than a million dollars on television advertising to fight back. According to OpenSecrets, there are currently about 1,500 registered drug or healthcare lobbyists in Congress with just under three members.

Merck CEO Ken Fraser, who helped fund advertising, strongly opposed the proposal because he believed the company would reduce revenue from recent phone calls with reporters. I am standing. However, he described the lobbying as altruistic, arguing that reduced profits would result in less funding for new treatments for the disease as well as research and development.

“We saw what happened,” Fraser said. “We model it and our ability to fund Merck’s research and development will be halved.”

PhRMA, the leading industry association for pharmaceutical companies, announced its first packaged advertising last month. In it, a woman named Sue looks into the camera and says a melancholy voice says that the Democratic Plan is “making it harder for Medicare people to get the drugs they need”. These ads are often shown on political news programs watched by politicians.

The association wants to go ahead with the complaint and let other accusing politicians decide “which drugs are available or not regardless of medical prescription”. A print advertising campaign followed, followed by open letters from 30 pharmaceutical companies.

At the same time, a group called Center Forward is running digital advertising targeted to help Democrats cut the bill. According to tax records, the company receives about $1.5 million per year from PhRMA.

“Thank you Kirsten Kino and tell her to keep fighting for Arizona as an independent voice,” said Kino, who discussed cutting elements of the President’s White House package so one of the ads was said.

“We can always count on Scott Peters to deliver,” said another, reaching out to voters in the California area, Congressman Scott Peters.

Pharmaceutical companies donate to lawmakers, but this year alone, Peters received more than $88,000 this year alone. He is one of three Democrats opposing Biden’s plans to cut the cost of prescription drugs on the Energy Trading Commission.

PhRMA claims its influence campaign isn’t trying to kill Biden’s trillion-dollar bill – they’re offering a cheaper alternative plan for the industry – but the end of the package lies elsewhere.

The US Chamber of Commerce and Industry, together with CEO Susan Clark, said, “Dramatically expanded the size and scope of the government through record low inflation costs and halted the fragile US economic recovery. I will impose a tax increase,” he accused the bill.

“The Chamber of Commerce will do everything possible to prevent the passage of the tax increase and murder bill,” Clark promised.

No Labels, an organization funded by West Virginia Democratic Senator Joe Manchin III and a firm closely linked to bipartisan House of Commons issues, was Biden’s first organization. He worked to get a trillion-dollar infrastructure plan off the ground but was upset about scrapping a broader social policy plan.

When Manchin called for a “stop” in Biden’s $3.5 trillion social policy plan, No Labels immediately ran an ad to support his “common sense” position.

The lobby has insulted liberals who accuse the company’s influence campaign of undermining the party’s top priorities.

“We see it on television every day,” said Congressman Washington Pramirajayapal, chairman of the Parliamentary Progressive Committee. He described intense lobbying by groups such as No Labels trying to scrap the plans. “It’s very sad because that’s the president’s agenda.”

No tags responded to requests for comment.

The American Dental Association mobilized its members against expanding Medicare to cover the benefits of dentistry, hearing and vision, arguing that it was too expensive for dentists. The American Revolutionary Petroleum Association is fighting for new tariffs and taxes for energy companies. They say this will increase customer costs. So is American oil

Leave a Comment

Your email address will not be published. Required fields are marked *